Document Detail


Second-generation antiepileptic drugs and pregnancy: a guide for clinicians.
MedLine Citation:
PMID:  22650173     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
When treating pregnant women with antiepileptic drugs (AEDs), clinicians have to balance potential fetal adverse effects against the risks of uncontrolled maternal disease. Only recently have emerging scientic data provided a rational basis for treatment decisions considering both aspects. The focus of research is currently moving from the first to the second AED generation. Lamotrigine is relatively well studied, and data on other novel AEDs, such as levetiracetam, oxcarbazepine, topiramate, zonisamide, gabapentin and pregabalin, are in progress. Safety issues appear to be favorable for lamotrigine, and preliminary results are also promising for levetiracetam and oxcarbazepine. Drugs metabolized by uridine-diphospate glucuronosyl transferase or excreted unchanged by the kidneys are particularly susceptible to increased body clearance during pregnancy. Lamotrigine is subject to both mechanisms, and therapeutic serum levels may sometimes be difficult to maintain. The authors review the recommendations and clinical research on modern AED treatment during pregnancy, highlighting current experience with second-generation drugs.
Authors:
Arne Reimers; Eylert Brodtkorb
Related Documents :
21627423 - Pregnancy outcome among grand multiparous women at the university of maiduguri teaching...
21951573 - Changes in the levels of factor viii and von willebrand factor in the puerperium.
6775353 - Prostaglandins and thromboxanes in amniotic fluid during rivanol-induced abortion and l...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of neurotherapeutics     Volume:  12     ISSN:  1744-8360     ISO Abbreviation:  Expert Rev Neurother     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-06-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101129944     Medline TA:  Expert Rev Neurother     Country:  England    
Other Details:
Languages:  eng     Pagination:  707-17     Citation Subset:  IM    
Affiliation:
Department of Clinical Pharmacology, St. Olavs University Hospital, 7006 Trondheim, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Autonomic dysfunction in Parkinson's disease.
Next Document:  The impact of positron emission tomography imaging on the clinical management of patients with epile...